SCHEMBL24437147

SCHEMBL24437147

Cc1ccc(S(=O)(=O)NC2CCc3cc(/C=C/C(=O)NOC4CCCCO4)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.40
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
HDAC4 P56524 3/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22500058 0.92 HDAC1 (0.42) HDAC1PDE4APDE4BPDE4CPDE4D
SCHEMBL22500118 0.87 HDAC1 (0.39) HDAC1PDE4APDE4BPDE4CPDE4D
SCHEMBL28659778 0.84 SMN1; SMN2 (0.40) HDAC1CA12CA1CA2CA7
SCHEMBL28659780 0.84 SMN1; SMN2 (0.40) HDAC1CA12CA1CA2CA7
SCHEMBL22517016 0.82 HDAC1 (0.55) HDAC1PDE4APDE4BPDE4CPDE4D
SCHEMBL24437231 0.81 CA12 (0.41) HDAC1PDE4APDE4BPDE4CPDE4D
SCHEMBL22516881 0.80 TGFBR1 (0.37) HDAC1ALDH1A1TGFBR1HPGD
SCHEMBL24437149 0.80 PDE4A (0.44) HDAC1PDE4APDE4BPDE4CPDE4D
SCHEMBL22517027 0.78 HDAC1 (0.36) HDAC1CA12CA1CA2CA7
SCHEMBL22501104 0.78 MEN1 (0.41) HDAC1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113660932-B Phenyl derivatives having pendant alkyl and alkenyl extensions and pharmaceutical compositions comprising the same 景凯生物科技股份有限公司 2024-07-12 CN disclosed
US-20220153687-A1 PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME TAIWANJ PHARMACEUTICALS CO., LTD. (TW) 2022-05-19 US disclosed
CN-113660932-A Phenyl derivatives with pendant alkyl and alkenyl extensions and pharmaceutical compositions comprising the same 景凯生物科技股份有限公司 2021-11-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153687-A1 PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME AADAC, ENPP2, ATXN10 HDAC1 21/4885PDE4A 2690/4885PDE4B 2584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.